Single User License
INR 16768
Site License
INR 33535
Corporate User License
INR 50303

Service Tax Additional

select a format
Price

Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Almac Group Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Almac Group Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH16726D
  • |
  • Pages: 35
  • |
  • November 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Almac Group Ltd(Almac) is a contract development and manufacturing organization provides a integrated services to pharmaceutical and biotechnology companies. The company offers a comprehensive range of services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to commercialization of products. Its services portfolio encompass diagnostics and biomarker development; clinical technologies; API (Active Pharmaceutical Ingriendient) services and chemical development; pharmaceutical development; analytical services; clinical services; and commercial services. The company operates through its subsidiaries in California, North Carolina and Pennsylvania in the US; Tokyo, Japan; and and Singapore.. Almac is headquartered in Craigavon, Northern Ireland, the UK.

Almac Group Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Almac Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Almac Group Ltd, Medical Devices Deals, 2010 to YTD 2016 9

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

Almac Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 11

Almac Acquires Noack N 623 Blister Packaging Line From Romaco Pharma 12

Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13

Partnerships 14

Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 14

McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 16

Almac Discovery Enters Into Agreement With Queen's University Belfast For Drug Discovery 17

Almac Enters Into Co-Development Agreement With University College London For Metagenomics, Enzyme Discovery Tools 19

Almac Enters Into Distribution Agreement With Affymetrix For Xcel Array 20

Beactica Enters Into Drug Discovery Agreement With Almac Discovery 21

BioFocus Enters Into An Agreement With Almac Group 22

Almac Group Enters Into Agreement With Exco InTouch 23

AEterna Zentaris Enters Into Co-Development Agreement With Almac 24

University College Cork Enters Into An Agreement With Almac Group 26

Licensing Agreements 27

Genentech Enters into Licensing Agreement with Almac Discovery 27

Galen Enters into Licensing Agreement with Medical Developments International for Penthrox 28

Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 29

Almac Group Ltd-Key Competitors 30

Key Employees 31

Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Almac Group Ltd, Medical Devices Deals, 2010 to YTD 2016 9

List of Tables

Almac Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2014 1

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Almac Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Almac Group Ltd, Deals By Therapy Area, 2010 to YTD 2016 8

Almac Group Ltd, Medical Devices Deals, 2010 to YTD 2016 9

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 11

Almac Acquires Noack N 623 Blister Packaging Line From Romaco Pharma 12

Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13

Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 14

McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 16

Almac Discovery Enters Into Agreement With Queen's University Belfast For Drug Discovery 17

Almac Enters Into Co-Development Agreement With University College London For Metagenomics, Enzyme Discovery Tools 19

Almac Enters Into Distribution Agreement With Affymetrix For Xcel Array 20

Beactica Enters Into Drug Discovery Agreement With Almac Discovery 21

BioFocus Enters Into An Agreement With Almac Group 22

Almac Group Enters Into Agreement With Exco InTouch 23

AEterna Zentaris Enters Into Co-Development Agreement With Almac 24

University College Cork Enters Into An Agreement With Almac Group 26

Genentech Enters into Licensing Agreement with Almac Discovery 27

Galen Enters into Licensing Agreement with Medical Developments International for Penthrox 28

Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 29

Almac Group Ltd, Key Competitors 30

Almac Group Ltd, Key Employees 31

Almac Group Ltd, Other Locations 32

Almac Group Ltd, Subsidiaries 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Almac Group Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com